Copyright
©The Author(s) 2019.
World J Clin Oncol. Feb 24, 2019; 10(2): 86-97
Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.86
Published online Feb 24, 2019. doi: 10.5306/wjco.v10.i2.86
Figure 1 Cumulative incidence of acute GvHD by total nucleated cell dose in myeloablative + total body irradiation conditioning.
A: Higher total nucleated cell dose had a higher incidence of acute GvHD grade II-IV; B: Total nucleated cell dose is not associated with acute GvHD grade III-IV; C: CD34+ cell dose is not associated with acute GvHD grade II-IV; D: Lower CD34+ cell dose has a higher incidence of acute GvHD grade III-IV. GvHD: Graft-versus-host disease.
Figure 2 OS by total nucleated cell dose.
A: OS was not significantly different in patients conditioned without TBI; B: OS was significantly better with a higher total nucleated cell dose in patients conditioned with TBI; C: OS was not significantly different in patients conditioned with myeloablative TBI; D: OS was significantly better with a higher total nucleated cell dose in patients conditioned with reduced intensity TBI. OS: Overall survival; TBI: Total body irradiation.
- Citation: Burns M, Singh AK, Hoefer CC, Zhang Y, Wallace PK, Chen GL, Platek A, Winslow TB, Iovoli AJ, Choi C, Ross M, McCarthy PL, Hahn T. Impact of conditioning regimen on peripheral blood hematopoietic cell transplant. World J Clin Oncol 2019; 10(2): 86-97
- URL: https://www.wjgnet.com/2218-4333/full/v10/i2/86.htm
- DOI: https://dx.doi.org/10.5306/wjco.v10.i2.86